Velarion Records
Free. Unsubscribe any time.

Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals, Inc. filed 11 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 11 transactions and 17,411 shares. None carries the SEC's AFF10B5ONE flag; all 11 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in Amphastar Pharmaceuticals, Inc. 11

Adoption dates in Amphastar Pharmaceuticals, Inc. 3

Results prints in Amphastar Pharmaceuticals, Inc. 7

Trades before a print in Amphastar Pharmaceuticals, Inc. 1

Interval to Amphastar Pharmaceuticals, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Amphastar Pharmaceuticals, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on March 10, 2026”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.